CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
Authors
Keywords
CXCR4, AMD3100, Tumor cell mobilization, Radiosensitivity
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 31, Issue 7, Pages 829-839
Publisher
Springer Nature
Online
2014-08-25
DOI
10.1007/s10585-014-9673-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer
- (2015) Colin D. Weekes et al. NEOPLASIA
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer
- (2014) M. D. Galsky et al. CLINICAL CANCER RESEARCH
- Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
- (2014) Donald Wong et al. BMC Urology
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
- (2012) W. Zhuo et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Emerging Pathways Mediating Growth, Invasion, and Metastasis of Tumors Progressing in an Irradiated Microenvironment
- (2012) F. Kuonen et al. CLINICAL CANCER RESEARCH
- CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein
- (2012) Owen J. McGinn et al. JOURNAL OF CELL SCIENCE
- Neovascularization After Irradiation: What is the Source of Newly Formed Vessels in Recurring Tumors?
- (2012) S. V. Kozin et al. JNCI-Journal of the National Cancer Institute
- Microenvironment and Radiation Therapy
- (2012) Michio Yoshimura et al. Biomed Research International
- Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging
- (2011) Alessio Giubellino et al. CANCER LETTERS
- Combined Blockade of Integrin- 4 1 Plus Cytokines SDF-1 or IL-1 Potently Inhibits Tumor Inflammation and Growth
- (2011) M. C. Schmid et al. CANCER RESEARCH
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
- (2011) M P Rettig et al. LEUKEMIA
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation
- (2010) S. V. Kozin et al. CANCER RESEARCH
- Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases
- (2010) Daisuke Uchida et al. EUROPEAN JOURNAL OF CANCER
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
- (2009) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+cell to Imatinib and Nilotinib
- (2009) Falk Dillmann et al. LEUKEMIA & LYMPHOMA
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- Plerixafor
- (2009) John F. DiPersio et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now